Latest Interviews
Showing 1216–1230 of 1,990 transcripts.
Clear all filters- Milken Institute1h 0m
The Future of Workforce in California: Industry Trends and Employment Pipelines
Jane Oates, Elise Stribos, Jeanie Wade, Ryan Craig, Diane Helfrey, Jessica Koo Kim
This summit addressed the critical displacement of traditional manufacturing roles by automation and the urgent need to bridge the digital skills gap across California's Los Angeles Basin workforce ecosystem. Industry leaders from E-Velocity and Northrop Grumman, alongside experts like Ryan Craig, highlighted successful intermediation models and strategic partnerships that align K-12, community college, and corporate curriculum with real-time labor market demands. The event concluded with consensus that the obsolete "40-year degree" model must be replaced by continuous upskilling, apprenticeship pathways, and inclusive hiring practices to sustain economic mobility in the 21st century.
- Y Combinator9 min
Why Does Your Company Deserve More Money? by Michael Seibel
Founders who have exhausted early-stage capital without achieving product-market fit are advised to cut burn and pursue break-even revenue rather than seeking additional investment, a strategy validated by the speaker's personal experience at Justin.TV. This shift from appeasing investors to focusing on user needs generates the leverage required to navigate Series A funding, where tangible financial performance and existing traction effectively replace concept-heavy pitches. Companies that enter later fundraising stages with independent revenue and market validation secure a distinct advantage by demonstrating quiet strength through data rather than elaborate narratives.
- Milken Institute47 min
Cast of 'Crazy Rich Asians' Talk of Movie's Impact on Pop Culture
Michelle Yeoh, John Chu, Kevin Kwan, John Phanon
Produced outside the traditional studio system by Nina Jacobson and Brad Simpson, *Crazy Rich Asians* defied early executive skepticism to achieve over $170 million in global box office revenue while securing key cast members like Michelle Yeoh and Jon M. Chu. The film leverages strategic partnerships to navigate international markets and aims to establish a sustainable industry precedent where Asian-led stories are viewed as viable investments rather than niche experiments. By normalizing diverse representation and fostering co-productions, the project positions itself as a cultural tipping point expected to influence future Hollywood financing and global storytelling dynamics.
- Milken Institute10 min
Building the Future of Health Data
Faster Cures, a center of the Milken Institute, launched a strategic initiative to accelerate medical advancement by empowering patients through the "Health Data Basics" framework and a new community of early adopters. The program aims to resolve systemic trust deficits by co-creating ethical standards for accessible, secure health data that integrates genomic, clinical, and daily digital metrics to improve outcomes. Following a call to action for stakeholders to join this movement, the organization asserts that leveraging data from patients' everyday environments is essential for predicting disease trajectories and developing targeted therapies.
- Y Combinator16 min
Why You Should or Should Not Work at a Startup by Justin Kan
Four-time YC participant and Atrium founder Justin Kahn argues that early-stage startups offer unmatched acceleration in professional growth, regardless of whether the venture succeeds or fails. Through case studies of founders like Kyle Vogt and Guillaume, Kahn demonstrates how unqualified employees rapidly ascend to critical responsibilities and later achieve massive scale or found billion-dollar companies like Cruise. He contends that the "slope" of personal learning in a chaotic startup environment far outweighs the stability and defined paths offered by established tech giants.
- Milken Institute1h 1m
Healthy People, Healthy Planet: Creating a Sustainable Ecosystem
Ryan Shadrick Wilson, Dan Barber, Bill Cassidy, Michael Milken, Walter Robb
A speaker delivered a fragmented session marked by technical failures, personal distress, and incoherent repetition rather than substantive policy or data. While alluding to a crisis and a potential future project, the speaker failed to provide specific details on events in New Orleans and New York or confirm any definitive outcomes. The presentation concluded without offering actionable information, instead highlighting the speaker's physical exhaustion and an inability to address the questions posed.
- Milken Institute1h 0m
Smart Cities for Healthy Aging
Paul Irving, Liddy Manson, David Ryan, Emily Shea, Lauren Steingold, Sarah Dash
Urban leaders and technology partners are shifting focus from siloed national reforms to city-scale integration, utilizing data-driven strategies to address transportation barriers, housing retention, and social isolation for an aging demographic. Boston exemplifies this approach through initiatives like Vision Zero safety sensors and public restroom mapping, while healthcare organizations leverage platforms like Uber Health and AI predictive analytics to ensure equitable patient access and preventive care. This collaborative framework emphasizes intergenerational infrastructure and high-touch design to bridge the digital divide, proving that scalable solutions require municipal leadership to align policy, business models, and technology for universal benefit.
- Milken Institute29 min
A Conversation with Francis Collins, Director, National Institutes of Health
Francis Collins, Meg Tirrell, Richard Ditizio, Synim Rivers
The event highlights a critical gender and racial leadership gap in healthcare, where women comprise half the workforce but hold only 3% of CEO roles, prompting organizations like Horizon Pharma to sign diversity pledges and adopt business resource groups to drive financial and clinical innovation. Parallel to these corporate initiatives, the NIH's "All of Us" research program and the Brain Initiative are launching large-scale, data-driven efforts to individualize medicine and accelerate cures for Alzheimer's and other neurological conditions by mapping billions of neurons and enrolling a diverse cohort of one million participants. These combined strategies aim to transform healthcare from a one-size-fits-all model into a precision-based system supported by robust funding, emerging gene therapies for sickle cell disease, and immunotherapy breakthroughs for metastatic cancers.
- Milken Institute1h 1m
System Thinking to Drive Patient Engagement: Walking the Talk
Susan Schaeffer, Julie Gerberding, Ivor Horn, Kathy Hudson, Bray Patrick-Lake, Janet Woodcock, Arthur Allen, Syra
Regulatory leaders, including FDA Director Janet Woodcock, and biopharmaceutical executives like Merck's Julie Gerberding discussed how the 21st Century Cures Act and PDUFA reauthorizations have institutionalized patient input to reshape drug development protocols. Panelists highlighted that early engagement reduces costly trial amendments while shifting metrics from clinical markers to patient-reported outcomes, as evidenced by approvals for conditions like multiple sclerosis and Duchenne muscular dystrophy. Despite challenges regarding diversity and internal cultural shifts, the consensus emphasizes that integrating lived experience into benefit-risk assessments accelerates innovation and aligns industry practices with patient needs.
- Milken Institute57 min
Confronting the Obesity and Diabetes Epidemics
William Dietz, Kelly Close, Sean Duffy, Mark Hyman, Joshua Riff, Hugh Waters
This panel addresses the $3.4 trillion annual economic burden of chronic diseases in the U.S., where obesity drives nearly half the costs and disproportionately affects underserved populations through a broken primary care capacity. Experts from organizations like Cleveland Clinic, Omada, and OnDuo demonstrated that community-based food pharmacy models and digital health platforms can dramatically reverse conditions like diabetes and heart failure while reducing costs by up to 80%. To scale these life-saving interventions, the discussion emphasized an urgent need to shift from episodic "sick care" to value-based reimbursement systems that fund "food as medicine" and community health workers.
- Milken Institute57 min
Race, Gender, and Work: The Economics of Healthy Aging
Patricia (Pat) Milligan, William Dow, Sarita Gupta, Cara James, Lisa Margeson, Debra Whitman
A comprehensive analysis of systemic inequalities reveals that women face significant wealth and health disadvantages driven by caregiving burdens, racial disparities, and labor force interruptions that cost the average female caregiver $300,000 in lost benefits. While structural barriers like age discrimination and a cultural silence on personal finance exacerbate these gaps, progressive policy interventions such as Hawaii's Kāpūna Caregiver Program and Washington's Long-Term Care Trust Act are beginning to revalue unpaid care work. Economic experts and major corporations now advocate for universal family care insurance and expanded paid leave to normalize caregiving across genders and close the persistent wealth gap.
- Milken Institute58 min
Loneliness as a Risk Factor: Making Connections to Improve Health
Lisa Marsh Ryerson, Lynn Goldman, Sachin Jain, Jeremy Nobel, Anand Parekh, Brian Van Buren, Phyllis Foxworth, Satya
Experts, healthcare leaders, and policymakers convened to address the rising epidemic of loneliness and social isolation, which carry mortality risks comparable to smoking and exacerbate syndemics with obesity and addiction. The discussion highlighted disproportionate impacts on marginalized groups, such as LGBTQ elders and rural communities, while showcasing successful business models like CareMore Health's social prescriptions that have driven a 75% increase in patient engagement. Strategic recommendations included adopting national screening metrics, integrating connection into value-based care, and deploying human-centered interventions to mitigate the $7 billion annual Medicare burden and reverse declining life expectancy.
- Milken Institute1h 1m
Creating a Culture of Biomedical Innovation
Mike Rea, Christopher Austin, Amitabh Chandra, Margaret Hamburg, Jennifer Miller, Jason Spangler
A cross-sector panel comprising leaders from NCATS, the FDA, Harvard, and Amgen redefined biomedical innovation as a value-driven process that balances patient outcomes with accessibility and ethical trust. By advocating for a collaborative culture that normalizes failure and breaks down silos between research, regulation, and reimbursement, the group proposed shifting metrics from simple speed to societal acceleration and integrity. The discussion ultimately highlighted critical misalignments in R&D funding, noting that commercial incentives currently neglect major disease burdens like mental health and neglected tropical diseases, necessitating a structural shift toward public-sector leadership.
- Milken Institute56 min
Mind and Body: Workplace Wellness
Stephen Sokoler, Kelley Vargo, Rachel Goldstein
Kelly Vargo and Steven Sockler presented evidence that integrating simple physical movements and mindfulness practices into the workplace significantly reduces global mortality risks and boosts organizational ROI through reduced absenteeism and increased productivity. Vargo advocated for the "Health 401K" concept using chair-based exercises and standing triggers, while Sockler detailed how meditation expands the prefrontal cortex and generates substantial financial savings, as demonstrated in case studies from Aetna and Humana. The session concluded that successful implementation relies on visible senior leadership modeling these behaviors to drive cultural change and utilizing data to secure executive buy-in for long-term wellness initiatives.
- Milken Institute1h 0m
Brain Health for Longevity: What Works? What Doesn't?
Nora Super, Alvaro Fernandez, Sarah Lock, David Perlmutter, Alfred Sandrock, Brian Van Buren, Jeff Wilkinson, Dr. Mark Hyman, Joe Maroon, Mark Fisher
Amidst a rapidly aging U.S. population where one in five residents will be over 65 by 2030, this event examines the convergence of biological mechanisms like autophagy and clinical breakthroughs to address the $716 trillion economic impact of cognitive decline. Panelists discuss a critical shift from late-stage treatment to early prevention, detailing how multimodal interventions—including sleep optimization, vascular health management, and disease-modifying therapies in the DIAN trial—can delay dementia onset by five to ten years. The discussion further emphasizes the necessity of overcoming diagnostic stigma and equity gaps to integrate neurotechnology and community support systems into a comprehensive public health strategy for brain longevity.